NutriBand (NTRB) Payables (2016 - 2026)
NutriBand (NTRB) posted Payables of $768530.0 for Q2 2026, up 21.69% sequentially from $631525.0 in Q1 2026, and down 9.59% YoY from $850062.0 in Q2 2025.
NutriBand (NTRB) Payables (2016 - 2026) Analysis & Trends
NutriBand has reported Payables for 11 years, with the latest figure at $768530.0 in Q2 2026.
- Quarterly Payables fell 9.59% year-over-year to $768530.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $768530.0 (down 9.59% YoY) and the FY2026 annual result came in at $631525.0, down 23.63% from the prior year.
- Payables rose to $768530.0 in Q2 2026 per NTRB's latest filing, from $631525.0 in the prior quarter.
- Over five years, Payables peaked at $1.4 million in Q3 2025 and troughed at $514774.0 in Q4 2023.
- A 5-year average of $756710.0 and a median of $693743.0 in 2022 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2024: Payables tumbled 38.12% in 2022, then surged 98.16% in 2024.
- Over 5 years, Payables stood at $557176.0 in 2022, then retreated by 7.61% to $514774.0 in 2023, then jumped by 98.16% to $1.0 million in 2024, then slipped by 28.06% to $733828.0 in 2025, then climbed by 4.73% to $768530.0 in 2026.
- According to Business Quant data, Payables over the past three periods registered $768530.0, $631525.0, and $733828.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 768,530.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 768,530.00 |
| Jan 31, 2026 | 631,525.00 |
| Oct 31, 2025 | 733,828.00 |
| Jul 31, 2025 | 1.41 Mn |
| Apr 30, 2025 | 850,062.00 |
| Jan 31, 2025 | 826,965.00 |
| Oct 31, 2024 | 1.02 Mn |
| Jul 31, 2024 | 906,486.00 |
| Apr 30, 2024 | 1.01 Mn |
| Jan 31, 2024 | 807,315.00 |
| Oct 31, 2023 | 514,774.00 |
| Jul 31, 2023 | 623,487.00 |
| Apr 30, 2023 | 563,684.00 |
| Jan 31, 2023 | 554,419.00 |
| Oct 31, 2022 | 557,176.00 |
| Jul 31, 2022 | 638,484.00 |
| Apr 30, 2022 | 549,559.00 |
| Jan 31, 2022 | 653,658.00 |
| Oct 31, 2021 | 658,662.00 |
| Jul 31, 2021 | 989,715.00 |